Clinical trial
Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino…
NCT00290329 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00290329 |
|---|---|
| Title | Safety of Purified Meningococcal Vaccine With Serogroups ACWY, in 3,000 Filipino Subjects Aged > 2 Years |
| Official title | Multicentric, Surveillance Study to Monitor Safety of GSK Biologicals' Purified Meningococcal Polysaccharide Vaccine of Serogroups ACWY in 3,000 Filipino Subjects Aged Above 2 Years When Administered According to the Prescribing Information. |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Infections, Meningococcal |
| Intervention type | Biological |
| Interventions | Mencevax ACWY |
| Enrollment | 249 |
| Start date | Jan 14, 2006 |
| Primary completion | Oct 1, 2006 |
| Completion | Oct 17, 2006 |
| First posted | Feb 13, 2006 |
| Last update posted | Jun 8, 2018 |
| Countries | Philippines |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: